Navigation Links
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
Date:5/14/2009

he demographic and blinded safety data from the ongoing Phase III study, the LUX-Lung 1 trial, will be presented at ASCO for the first time.(5)

The LUX-Lung 1 study addresses a critical need for treatment options for NSCLC patients after failure with a second-line or third-line reversible EGFR inhibitor (i.e., erlotinib or gefitinib). This study recently moved from Phase IIb into Phase III.(5)

"The LUX-Lung 1 study is important as it investigates BIBW 2992 in a group of patients for whom there are no other approved treatment options. These are patients who have already been through standard first-line or second-line chemotherapy and then received treatment with an EGFR TKI. The LUX-Lung 1 study will evaluate whether BIBW 2992 will extend the lives of these cancer patients,"(5) said Dr. Haehl.

First Presentation of Phase II Data on BIBF 1120 in Ovarian Cancer

Data from a Phase II study of BIBF 1120 in patients with ovarian cancer who responded to at least second-line chemotherapy will be presented at ASCO in Orlando. The study showed a potential delay in disease progression: With BIBF 1120 the median time to RECIST progression was 4.8, versus 2.8 for placebo.(11) BIBF 1120 is an oral compound that works by simultaneously inhibiting vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs) and fibroblast growth factor receptors (FGFRs) -- all factors which are involved in the formation of blood vessels, a process known as angiogenesis.(12,13).

"There is a great need for more effective and well tolerated treatment options for women with ovarian cancer.(14) We have a growing body of evidence that anti-angiogenic agents may represent an important treatment approach for this disease,"(15,16,17) commented Prof. Jonathan A. Ledermann, MD, Professor of Medical Oncology & Director at the Cancer Research UK & UCL Cancer Trials
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
(Date:8/29/2014)... WASHINGTON , Aug. 29, 2014 Diseases ... a generation ago are returning. Measles was declared ... cases in 2014 as of August 15—the highest incidence ... public health department declared whooping cough a problem ... children are getting sick and dying from these preventable ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... leading Clinical Research Organization, will exhibit at the 61st ... Liver Diseases, The Liver Meeting®, being held 30 October ... Representatives from PRA,s Infectious Diseases Research Center and ... discuss our expertise in hepatitis B & C as ...
... ANN ARBOR, Mich., Oct. 28 Adeona Pharmaceuticals, Inc., (AMEX: ... hold its Annual Shareholders Meeting on Tuesday, November 2, from ... 3930 Varsity Drive, Ann Arbor, MI, 48108. ... S. Kuo, M.D., M.B.A., will give an update on the ...
Cached Medicine Technology:PRA International to Exhibit at Liver Diseases Conference 2
(Date:9/1/2014)... Ontraport , one of the latest ... to automate the small intricacies of managing an online ... prompting an investigative review. , “As a new ... all of the small details involved with running a ... “That’s why Ontraport has become so popular in this ...
(Date:9/1/2014)... Pastor Thompson is an ordained minister and ... He is a licensed minister through the Church of the ... years in New Mexico, Colorado and North Dakota. He and ... year. He also has two beautiful daughters, Brianna, 22 ... Ministry from Nazarene Bible College, in Colorado Springs and is ...
(Date:9/1/2014)... 2014 This Flash Report ... perspectives on stakeholder management needs ... flash report to speak with Heartbeat Experts ... product:, ,     Position clinically meaningful ... market ,     Understanding stakeholder interactions with ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 The FDA ... Nutrition Facts label. If adopted, the proposed changes would ... addition of “added sugars” on the label, and a ... to keep “added sugars” off the label. NutriGold fully ... consumers make healthier food choices. “After 20 years, it's ...
(Date:8/31/2014)... Mesa, Arizona (PRWEB) August 31, 2014 For ... ragweed is likely the culprit. Ragweed is the most common ... percent of Americans. , The most common symptoms of ragweed ... and throat, and sneezing. Ragweed allergy can also lead to ... ragweed allergies should consult an allergist about allergy immunotherapy - ...
Breaking Medicine News(10 mins):Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Diabetes Products 2Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 2Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 3Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 4Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3
... to really pan out, expert warns , , THURSDAY, June 26 ... an immune response to an investigational vaccine lived twice as ... research shows. , "If you were an immune responder, you ... Dr. Susan Domchek, an associate professor of medicine at the ...
... Superior Efficacy to Avastin at Improving Visual Acuity When, ... Percent Patient Share, ... from Decision Resources, WALTHAM, Mass., June 26 ... firms focusing on pharmaceutical and,healthcare issues, finds that Genentech/Novartis,s ...
... MINNEAPOLIS, June 26 ACM today announced ... Bryngelson as the company,s new,Executive Vice President ... development, operations, and client service management, Ms.,Bryngelson ... components of,ACM,s infrastructure -- including technology, call ...
... Home Medical,Equipment, Inc. (Pink Sheets: SHMM) announced today ... has completed its seventh,staffing agreement and is aggressively ... and CEO of parent company Southern Home Medical,stated, ... team has far,exceeded their own expectations in their ...
... 26 "The time is right and the,wording is ... "This bill recognizes the God-given Right to Life of ... will end the slaughter of,innocent children.", S.3111, introduced ... is scheduled for debate in the Senate Committee on ...
... Therapeutics (Prime),announced today the hiring of Jerry Steffl ... for developing Prime,s position on,policy issues at both ... approach to government affairs both internally and with ... Prime,s lobbying,efforts with industry associations and trade groups, ...
Cached Medicine News:Health News:Breast Cancer Vaccines Look Promising 2Health News:Breast Cancer Vaccines Look Promising 3Health News:Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy 2Health News:ACM Adds Top Industry Executive to Its Leadership Team 2Health News:Encore Medical Staffing of Greenville Signs Seventh Staffing Agreement 2
Irrigation pump for arthroscopy....
... in Arthroscopy. Ease of use and superior ... the 10k Fluid System unique. , ,The ... maintains intra-articular pressure, while providing instantaneous flow ... when used for Laparoscopy, provides instantaneous fluid ...
... CD / DVD Burner captures still ... to 50 patient archives allows for ... future retrieval. The unit provides software ... for easy playback and editing. Compatible ...
... The new MicroLux® Digital Video Recorder gives you ... and store your surgical cases. THE DVR is ... life-like presentations. With its convenient mouse and footswitch, ... procedure you need - no more hours of ...
Medicine Products: